Cargando…

Bacterially Produced Recombinant Influenza Vaccines Based on Virus-Like Particles

Although current influenza vaccines are effective in general, there is an urgent need for the development of new technologies to improve vaccine production timelines, capacities and immunogenicity. Herein, we describe the development of an influenza vaccine technology which enables recombinant produ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jegerlehner, Andrea, Zabel, Franziska, Langer, Alice, Dietmeier, Klaus, Jennings, Gary T., Saudan, Philippe, Bachmann, Martin F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832520/ https://www.ncbi.nlm.nih.gov/pubmed/24260136 http://dx.doi.org/10.1371/journal.pone.0078947

Ejemplares similares

Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy
por: Schmitz, Nicole, et al.
Publicado: (2009)

Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines
por: Gomes, Ariane C., et al.
Publicado: (2017)

Versatile Virus-Like Particle Carrier for Epitope Based Vaccines
por: Tissot, Alain C., et al.
Publicado: (2010)

Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy
por: Zeltins, Andris, et al.
Publicado: (2017)

Virus-Like Particles Produced Using the Brome Mosaic Virus Recombinant Capsid Protein Expressed in a Bacterial System
por: Strugała, Aleksander, et al.
Publicado: (2021)

Production of influenza virus-like particles using recombinant insect cells
por: Matsuda, Takuya, et al.
Publicado: (2020)

Bacterial expression systems based on Tymovirus-like particles for the presentation of vaccine antigens
por: Ogrina, Anete, et al.
Publicado: (2023)

Immunogenicity and Antigenicity of Rabbit Hepatitis E Virus-Like Particles Produced by Recombinant Baculoviruses
por: Bai, Huimin, et al.
Publicado: (2021)

Efficacious Recombinant Influenza Vaccines Produced by High Yield Bacterial Expression: A Solution to Global Pandemic and Seasonal Needs
por: Song, Langzhou, et al.
Publicado: (2008)

Dose immunogenicity study of a plant-produced influenza virus-like particle vaccine in layer hens
por: Abolnik, Celia, et al.
Publicado: (2022)

Comparison of Bacterial Expression Systems Based on Potato Virus Y-like Particles for Vaccine Generation
por: Ogrina, Anete, et al.
Publicado: (2022)

Special Issue “Virus-Like Particle Vaccines”
por: Vogel, Monique, et al.
Publicado: (2020)

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
por: Doucet, Marika, et al.
Publicado: (2017)

The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants
por: Jul-Larsen, Åsne, et al.
Publicado: (2012)

Development of a Plasmodium vivax malaria vaccine for clinical applications using transgenic parasites, virus-like particles and recombinant viruses
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2014)

A Chimeric Sudan Virus-Like Particle Vaccine Candidate Produced by a Recombinant Baculovirus System Induces Specific Immune Responses in Mice and Horses
por: Wu, Fangfang, et al.
Publicado: (2020)

Immunogenicity and protective efficacy of human metapneumovirus virus-like particles produced by a recombinant baculovirus in mice
por: Ma, Fenlian, et al.
Publicado: (2023)

Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine
por: Skibinski, David A. G., et al.
Publicado: (2013)

Recombinant Influenza Vaccines
por: Sedova, E.S., et al.
Publicado: (2012)

Virus‐like particles for vaccination against cancer
por: Mohsen, Mona O., et al.
Publicado: (2019)

Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against Influenza A M2 protein
por: Beerli, Roger R, et al.
Publicado: (2009)

The Standard Model of Particle Physics as a Conspiracy Theory and the Possible Role of the Higgs Boson in the Evolution of the Early Universe
por: Jegerlehner, Fred
Publicado: (2021)

A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine
por: Leroux-Roels, Isabel, et al.
Publicado: (2022)

Recombinant Vectors as Influenza Vaccines
por: Kopecky-Bromberg, Sarah A., et al.
Publicado: (2009)

Porcine Deltacoronavirus-like Particles Produced by a Single Recombinant Baculovirus Elicit Virus-Specific Immune Responses in Mice
por: Liu, Yangkun, et al.
Publicado: (2023)

Efficacy of a plant‐produced virus‐like particle vaccine in chickens challenged with Influenza A H6N2 virus
por: Smith, Tanja, et al.
Publicado: (2019)

Effective Chikungunya Virus-like Particle Vaccine Produced in Insect Cells
por: Metz, Stefan W., et al.
Publicado: (2013)

Vaccination against GIP for the Treatment of Obesity
por: Fulurija, Alma, et al.
Publicado: (2008)

Cystatin F is a biomarker of prion pathogenesis in mice
por: Nuvolone, Mario, et al.
Publicado: (2017)

Factors of early protective action of live influenza vaccine combined with recombinant bacterial polypeptides against homologous and heterologous influenza infection
por: Desheva, Yulia A., et al.
Publicado: (2019)

Zeuthen Workshop on Elementary-particle Theory : QCD and QED in Higher Orders
por: Blümlein, Johannes, et al.
Publicado: (1996)

Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties
por: Liu, Yan, et al.
Publicado: (2014)

Progress and hurdles in the development of influenza virus-like particle vaccines for veterinary use
por: Lee, Dong-Hun, et al.
Publicado: (2014)

The 3Ds in virus‐like particle based‐vaccines: “Design, Delivery and Dynamics”
por: Mohsen, Mona O., et al.
Publicado: (2020)

Recombinant Virus-like Particles of Human Parvovirus B19 with the Internal Location of VP1 Unique Region Produced by Hansenula polymorpha
por: Shao, Shuai, et al.
Publicado: (2022)

Recombination produces coherent bacterial species clusters in both core and accessory genomes
por: Marttinen, Pekka, et al.
Publicado: (2015)

Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs
por: Kang, Hae-Ji, et al.
Publicado: (2019)

Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic
por: López-Macías, Constantino
Publicado: (2012)

Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies
por: Djender, Selma, et al.
Publicado: (2014)

T-helper Cell-Mediated Proliferation and Cytokine Responses against Recombinant Merkel Cell Polyomavirus-Like Particles
por: Kumar, Arun, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kcvp06p6hmtp3t8ppeies2ouvf